VSA-2:一种新型植物来源佐剂用于SARS-CoV-2亚单位疫苗
QS-21作为多种获批疫苗的关键成分面临供应有限、剂量限制性毒性等局限,亟需开发保留其佐剂活性而无其缺点的皂苷替代品。研究将酰胺侧链引入可持续来源的木鳖皂苷I和II,获得半合成免疫刺激佐剂VSA-1和VSA-2。本研究表明,VSA-2佐剂的SARS-CoV-2受体结合蛋白(RBD)在小鼠中诱导了与QS-21-RBD疫苗相当的高滴度SARS-CoV-2特异性体液和Th1倾向免疫应答。VSA-2-RBD疫苗接种对SARS-CoV-2及变异株感染提供了强保护,并同样减轻病毒诱导的肺部炎症和病理。总体而言,VSA-2佐剂有望在传染病疫苗中补充临床验证的皂苷佐剂QS-21。
要点
- VSA-2佐剂SARS-CoV-2 RBD疫苗在小鼠中诱导与QS-21-RBD相当的体液和Th1免疫应答。
- VSA-2-RBD疫苗对SARS-CoV-2及变异株感染提供强保护并减轻肺部炎症和病理。
- VSA-2有望作为QS-21的补充佐剂用于传染病疫苗。
核心结论
- VSA-2佐剂可诱导与QS-21相当的SARS-CoV-2特异性免疫应答和保护效果,有望补充QS-21用于传染病疫苗。
研究设计与样本
- 研究在小鼠中比较VSA-2-RBD与QS-21-RBD疫苗的免疫原性和保护效果。
主要发现
- VSA-2-RBD诱导高滴度SARS-CoV-2特异性体液和Th1倾向免疫应答,与QS-21-RBD相当。
- VSA-2-RBD对SARS-CoV-2及变异株感染提供强保护,并减轻病毒诱导的肺部炎症和病理,与QS-21-RBD相似。
临床怎么用
- VSA-2可作为QS-21的潜在补充佐剂,用于SARS-CoV-2亚单位疫苗及传染病疫苗开发。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
QS-21, a key component of several licensed vaccines is facing limited supply, dose-limiting toxicity and other drawbacks which together limit its broader usage. Development of saponin alternatives to QS-21 that retain its desirable adjuvant activity without its drawbacks is in high need. Incorporating an amide side chain into the more sustainable Momordica saponins (MS) I and II led to the recent discovery of two semisynthetic immunostimulatory adjuvants VSA-1 and VSA-2. Here, we showed that SARS-CoV-2 receptor-binding protein (RBD) adjuvanted with VSA-2 induced high titers of SARS-CoV-2 specific humoral and T helper-1 prone immune responses in mice comparable to that triggered by QS-21-RBD vaccination. Vaccination with VSA-2-RBD provided strong protection against SARS-CoV-2 and variants infection and the virus-induced lung inflammation and pathology similarly as QS-21-RBD vaccination. Overall, our results suggest that VSA-2 adjuvant can potentially complement the clinically proven saponin adjuvant QS-21 in vaccines against infectious diseases.
引用
- Adam A, Lee C, Jones MC, et al. VSA-2-, a novel plant-derived adjuvant for SARS-CoV-2 subunit vaccine. Vaccine. 2026. PMID: 41576707. doi:10.1016/j.vaccine.2026.128255
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。